BertholfR.L., RomanJ.M., BrownS.Aluminium hydroxide induced osteomalacia, encephalopathy and hyperaluminemia in CAPD. Treatment with Desferroxamine.Perit Dial Bull1984; 4: 30–32.
2.
FalkR.J., Mat ternW.D., LamannaR.W.Iron removal during CAPD using Desferrioxamine.Kidney Int1983; 24: 110–112.
3.
OlivieriN.F., BuncicJ.R., ChewE.Visual and auditory neurotoxicity in patients receiving subcutaneous Deferoxamine infusions.New Engl J Med1986; 314: 869–873.
4.
StanbaughO.H., HolmesA.W., OillitD.Iron chelation therapy in CAPD; a new and effective treatment of iron overload disease in E.S.R.D. patients.Perit Dial Bull1983; 3: 99–101.
5.
WilliamsP., KhannaR., OrapperM.C.Enhancement of aluminium removal in a patient by Desferoxamine on CAPD with dementia.Perit Dial Bull1981; 1: 73.
